Bounded definition
A source-bounded method record for senolytic selectivity within longevity and metabolism.
What the cited work establishes
The study identifies candidate senolytic vulnerabilities and reports cell- and animal-model experiments for specified compounds.
Limited to Senescent-cell survival pathways, compound screening, cell assays, and mouse experiments. in “The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs”; this candidate records the concept boundary and does not pool results from uncited systems or studies.
Claims: urn:maha:claim:longevity-metabolism-senolytic-selectivity
What remains a separate question
Senolytic selectivity does not by itself establish system-level performance, safety, manufacturability, scalability, economic advantage, clinical benefit, or deployment readiness.
Preclinical selectivity and clearance results do not establish human safety, dosing, efficacy, or lifespan extension.
Claim ledger
Every proposition keeps its own evidence state.
The cited source supports treating senolytic selectivity as a distinct method within the stated longevity and metabolism scope.
- Scope
- Limited to Senescent-cell survival pathways, compound screening, cell assays, and mouse experiments. in “The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs”; this candidate records the concept boundary and does not pool results from uncited systems or studies.
- Boundary
- Senolytic selectivity does not by itself establish system-level performance, safety, manufacturability, scalability, economic advantage, clinical benefit, or deployment readiness.
- Uncertainty
- No cross-source quantitative interval is asserted. Definitions, operating conditions, samples, instruments, and outcome measures must be checked against the exact cited locator during review.
- Replication
- Independent replication and cross-platform transfer have not been compiled for this candidate; the evidence maturity refers only to the bounded source contract.
Primary sources
Citation, locator, rights, and boundary travel together.
Source 1 · Aging Cell
The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
Yi Zhu, Tamara Tchkonia, Tamar Pirtskhalava, et al.
- Exact locator
- Senescent-cell survival pathways, compound screening, cell assays, and mouse experiments.
- Establishes
- The study identifies candidate senolytic vulnerabilities and reports cell- and animal-model experiments for specified compounds.
- Boundary
- Preclinical selectivity and clearance results do not establish human safety, dosing, efficacy, or lifespan extension.
- Rights basis
- citation with paraphrase · The candidate uses original boundary language and a short paraphrase linked to the cited source. No source passage, figure, or table is reproduced.